NASDAQ:BCAB

BioAtla (BCAB) News Today

$1.51

-0.12 (-7.36%)

(As of 10/3/2023 ET)

Compare

Today's Range: $1.50
▼
$1.66
50-Day Range: $1.51
▼
$3.00
52-Week Range: $1.50
▼
$11.73

Volume: 246,059 shs
Average Volume: 512,721 shs
Market Capitalization: $72.18 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $14.83

Source

Source	Headline
	BioAtla (NASDAQ:BCAB) Given New $14.00 Price Target at JPMorgan Chase & Co. americanbankingnews.com - September 26 at 2:46 AM
	Analyst Ratings for BioAtla markets.businessinsider.com - September 25 at 3:27 PM
	BioAtla, Inc. (NASDAQ:BCAB) Given Consensus Rating of "Moderate Buy" by Brokerages americanbankingnews.com - September 25 at 4:20 AM
	MYDA Advisors LLC Takes $147,000 Position in BioAtla, Inc. (NASDAQ:BCAB) marketbeat.com - September 10 at 5:22 AM
	BioAtla to Participate in the H.C. Wainwright 25th Annual Global Investment Conference finance.yahoo.com - September 6 at 7:29 PM
	BioAtla, Inc. (NASDAQ:BCAB) Receives Consensus Recommendation of "Moderate Buy" from Analysts marketbeat.com - August 31 at 3:20 AM
	Connor Clark & Lunn Investment Management Ltd. Acquires Shares of 48,614 BioAtla, Inc. (NASDAQ:BCAB) marketbeat.com - August 29 at 4:49 AM
	Q3 2023 EPS Estimates for BioAtla, Inc. (NASDAQ:BCAB) Lowered by Analyst marketbeat.com - August 4 at 9:49 AM
	BioAtla to Participate in Upcoming Investor Conferences in August finance.yahoo.com - August 3 at 8:18 PM
	Analysts Offer Insights on Healthcare Companies: BioAtla (BCAB), Exelixis (EXEL) and Steris (STE) markets.businessinsider.com - August 3 at 10:16 AM
	JP Morgan Maintains BioAtla (BCAB) Overweight Recommendation msn.com - August 3 at 10:16 AM
	JMP Securities Reiterates BioAtla (BCAB) Market Outperform Recommendation msn.com - August 3 at 10:16 AM
	BioAtla, Inc. (NASDAQ:BCAB) Q2 2023 Earnings Call Transcript finance.yahoo.com - August 3 at 10:16 AM
	H.C. Wainwright Reaffirms Their Buy Rating on BioAtla (BCAB) markets.businessinsider.com - August 2 at 8:51 AM
	BioAtla Reports Second Quarter 2023 Financial Results and Highlights Recent Progress finance.yahoo.com - August 1 at 5:48 PM
	BioAtla (BCAB) Scheduled to Post Earnings on Tuesday marketbeat.com - July 26 at 5:12 PM
	BioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023 finance.yahoo.com - July 25 at 12:14 PM
	BioAtla, Inc. (NASDAQ:BCAB) Given Average Rating of "Moderate Buy" by Brokerages marketbeat.com - July 12 at 4:11 AM
	With 51% ownership of the shares, BioAtla, Inc. (NASDAQ:BCAB) is heavily dominated by institutional owners finance.yahoo.com - July 7 at 7:35 AM
	BioAtla (BCAB) Price Target Increased by 9.33% to 16.73 msn.com - July 6 at 8:45 PM
	BioAtla, Inc. (NASDAQ:BCAB) Holdings Boosted by Vontobel Holding Ltd. marketbeat.com - June 28 at 4:43 AM
	BioAtla Added to Membership of U.S. Small-Cap Russell 2000® Index finance.yahoo.com - June 26 at 8:16 AM
	Endurant Capital Management LP Makes New Investment in BioAtla, Inc. (NASDAQ:BCAB) marketbeat.com - June 14 at 12:07 PM
	Citigroup Inc. Boosts Position in BioAtla, Inc. (NASDAQ:BCAB) marketbeat.com - June 8 at 4:30 AM
	BioAtla to Participate in the Jefferies Healthcare Conference finance.yahoo.com - May 31 at 8:20 AM
	Opaleye Management Inc. Invests $2.16 Million in BioAtla, Inc. (NASDAQ:BCAB) marketbeat.com - May 26 at 2:50 PM
	BioAtla, Inc. (NASDAQ:BCAB) Given Consensus Recommendation of "Moderate Buy" by Brokerages marketbeat.com - May 23 at 4:12 AM
	Brokers Issue Forecasts for BioAtla, Inc.'s Q2 2023 Earnings (NASDAQ:BCAB) marketbeat.com - May 17 at 6:47 AM
	JMP Securities Reiterates BioAtla (BCAB) Outperform Recommendation msn.com - May 16 at 5:08 PM
	Where BioAtla Stands With Analysts markets.businessinsider.com - May 15 at 12:48 PM
	HC Wainwright & Co. Reiterates BioAtla (BCAB) Buy Recommendation msn.com - May 15 at 12:48 PM
	H.C. Wainwright Keeps Their Buy Rating on BioAtla (BCAB) markets.businessinsider.com - May 15 at 7:47 AM
	BioAtla (BCAB) Receives a Buy from JMP Securities markets.businessinsider.com - May 15 at 2:30 AM
	EF Hutton Reiterates BioAtla (BCAB) Buy Recommendation msn.com - May 13 at 5:37 PM
	BioAtla (BCAB) Receives a Buy from BTIG markets.businessinsider.com - May 12 at 8:52 AM
	BioAtla Reports First Quarter 2023 Financial Results and Highlights Recent Progress finance.yahoo.com - May 11 at 10:44 PM
	Bioatla (BCAB) Earnings Dates & Reports investing.com - May 11 at 12:43 PM
	BioAtla to Participate in the JMP Securities Life Sciences Conference finance.yahoo.com - May 8 at 6:11 PM
	BioAtla to Announce First Quarter 2023 Financial Results and Provide Business Highlights on May 11, 2023 finance.yahoo.com - May 4 at 8:52 AM
	We Think BioAtla (NASDAQ:BCAB) Needs To Drive Business Growth Carefully finance.yahoo.com - April 29 at 2:09 PM
	EF Hutton Maintains BioAtla (BCAB) Buy Recommendation msn.com - April 19 at 7:40 AM
	BioAtla, Inc. (NASDAQ:BCAB) Q4 2022 Earnings Call Transcript finance.yahoo.com - March 27 at 7:39 AM
	JMP Securities Keeps Their Buy Rating on BioAtla (BCAB) markets.businessinsider.com - March 27 at 1:59 AM
	BioAtla to Announce Fourth Quarter and Full-Year 2022 Financial Results and Provide Business Highlights finance.yahoo.com - March 16 at 12:55 PM
	795,000 Shares in BioAtla, Inc. (NASDAQ:BCAB) Bought by Eventide Asset Management LLC marketbeat.com - March 3 at 11:02 AM
	BioAtla Announces Change in Executive Leadership finance.yahoo.com - February 27 at 9:38 AM
	BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 Bispecific T-Cell Engager for the Treatment of Advanced Adenocarcinoma finance.yahoo.com - February 23 at 1:36 PM
	Massachusetts Financial Services Co. MA Grows Position in BioAtla, Inc. (NASDAQ:BCAB) marketbeat.com - February 15 at 5:15 AM
	Recent uptick might appease BioAtla, Inc. (NASDAQ:BCAB) institutional owners after losing 56% over the past year finance.yahoo.com - January 25 at 8:21 AM
	BioAtla (NASDAQ:BCAB) Earns Buy Rating from Analysts at EF Hutton Acquisition Co. I marketbeat.com - January 5 at 8:39 AM

Get BioAtla News Delivered to You Automatically

BCAB Media Mentions By Week

BCAB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BCAB
News Sentiment
▼
0.94

0.70
▲
Average
Medical
News Sentiment

BCAB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BCAB Articles
This Week
▼
0

1
▲
BCAB Articles
Average Week

Get BioAtla News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:BCAB) was last updated on 10/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

BioAtla (BCAB) News Today

BCAB Media Mentions By Week

BCAB Media Sentiment

BCAB News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info